22/06/2017 10:24

IAI successfully completes operational firing trial of the LORA weapon system

Israel Aerospace Industries (IAI) has successfully completed a firing trial with LORA (Long-Range Artillery weapon system) as the conclusive stage of several deals that involve the system. The trial consisted of launching a long-range LORA missile to a pre-planned target. IAI’s LORA weapon system is a focus at this week’s Paris Air Show.

LORA is an artillery weapon system, which consists of a long-range tactical ground-to-ground missile developed by IAI’s MALAM division. It is intended for strike scenarios with a range of up to 400 km and precision of 10 meters or better. The LORA missile weighs approximately 1,600 kg.

During the trial the ground version of the artillery weapon system was positioned on a naval vessel far out in the sea, in compliance with safety requirements for trials of this kind. The missile was launched from an operational system that consists of a command trailer and ground launcher. Following the launch, the missile has navigated its course to the target, striking the designated target with high precision. Both the weapon system and the missile have successfully met all objectives.

Joseph Weiss, IAI president and CEO, said, “This trial has demonstrated the advanced capabilities of LORA, the weapon system developed by IAI. LORA complements the range of missile systems developed by IAI to round up our fulfilment of our customers’ needs.”

Boaz Levi, Executive Vice President and General Manager of Systems, Missiles & Space Group said: “This was one of the most complex trials we held over the past few years and a technological breakthrough for IAI’s missile development operations. The trial was held according to a full operational outline, including an assessment of the system’s maneuvering, assault and precision capabilities. The impressive results attest to the system’s maturity and advanced capabilities.” Levy added, “I would like to thank Israel’s navy, air force, SIBAT and Ministry of Defense for the unusual collaboration which was reflected in the outstanding system performance in this trial.”